Dosing protocol · Weight Management
CagriSema dosing & administration
Cagrilintide and semaglutide together in one weekly injection. In the phase 3 REDEFINE 1 trial, people lost 20.4% of body weight over 68 weeks against 3.0% on placebo — 22.7% among those who stayed on treatment . Submitted to the US FDA in December 2025; not approved anywhere yet .
Suggested dose
0.25 – 2.4 mg